1887

Chapter 6 : Variable Capacity for Persistent Infection and Complications of Gram-Positive Cocci: Streptococci and Staphylococci

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Variable Capacity for Persistent Infection and Complications of Gram-Positive Cocci: Streptococci and Staphylococci, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815486/9781555814304_Chap06-1.gif /docserver/preview/fulltext/10.1128/9781555815486/9781555814304_Chap06-2.gif

Abstract:

This chapter focuses on two clinically important gram-positive genera, and , and the complications and persistent infections caused by these bacteria. Many streptococci are part of the normal flora of the mouth, skin, intestine, and upper respiratory tract. In the clinical laboratory, streptococci are differentiated based on their hemolytic properties on blood agar plates. Beta-hemolytic streptococci fully break down red blood cells, leaving a clear zone of true hemolysis around colonies. Beta-hemolytic streptococci are further divided into separate groups based on their Lancefield antigens. As with other streptococci, peptidoglycan and teichoic acid are the principal constituents of the pneumococcal cell wall. Non-dextran-producing streptococci may produce infective endocarditis (IE) in humans and adhere to artificial fibrinplatelet surfaces in vitro, which suggests that other characteristics are required. Ubiquitous colonizers of the skin and mucosa of most animals, the staphylococci are gram-positive cocci found singly, in pairs, or in grape-like clusters. Persistent infection is heavily mediated by the ability to elaborate biofilm. Biofilm-producing staphylococci are described primarily as coagulase-negative staphylococci (CoNS), and they are implicated in colonization and persistence on catheters and other prosthetic materials. Prosthetic devices can become contaminated with staphylococci at the time of insertion or due to contiguous spread of infection or through hematogenous seeding at the time of bacteremia. The most important predictors of complicated infection include persistent fever or bacteremia.

Citation: Ferguson B, Woods C. 2009. Variable Capacity for Persistent Infection and Complications of Gram-Positive Cocci: Streptococci and Staphylococci, p 87-106. In Fratamico P, Smith J, Brogden K (ed), Sequelae and Long-Term Consequences of Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555815486.ch6

Key Concept Ranking

Acute Respiratory Distress Syndrome
0.44886392
Tumor Necrosis Factor alpha
0.44548902
Restriction Fragment Length Polymorphism
0.4171015
0.44886392
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1.
Figure 1.

Electron micrograph of glomerular capillary wall in acute poststreptococcal glomerulonephritis showing hemispherical electron-dense deposit (“humps”) in subepithelial space. (Courtesy of David Howell.)

Citation: Ferguson B, Woods C. 2009. Variable Capacity for Persistent Infection and Complications of Gram-Positive Cocci: Streptococci and Staphylococci, p 87-106. In Fratamico P, Smith J, Brogden K (ed), Sequelae and Long-Term Consequences of Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555815486.ch6
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815486.ch06
1. Alexander, J. E.,, R. A. Lock,, C. C. Peeters,, J. T. Poolman,, P. W. Andrew,, T. J. Mitchell,, D. Hansman and, J. C. Paton. 1994. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 62:56835688.
2. Angel, C. S.,, M. Ruzek, and, M. K. Hostetter. 1994. Degradation of C3 by Streptococcus pneumoniae. J. Infect. Dis. 170:600608.
3. Archer, G. L.,, and M. W. Climo. 1994. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob. Agents Chemother. 38:22312237.
4. Ayoub, E. M.,, D. J. Barrett,, N. K. Maclaren, and, J. P. Krischer. 1986. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J. Clin. Investig. 77:20192026.
5. Azzam, Z. S.,, Y. Ron,, I. Oren,, W. Sbeit,, D. Motlak, and, N. Krivoy. 1998. Group B streptococcal tricuspid valve endocarditis: a case report and review of literature. Int. J. Cardiol. 64:259263.
6. Baddour, L. M.,, W. R. Wilson,, A. S. Bayer,, W. G. Fowler, Jr.,, A. F. Bolger,, M. W. Levison,, P. Ferrieri,, M. A. Gerber,, L. Y. Tani,, M. H. Gewitz,, D. C. Tong,, J. M. Steckelberg,, R. S. Baltimore,, S. T. Shulman,, J. C. Burns,, D. A. Falace,, J. W. Newburger,, T. J. Pallasch,, M. Takahashi,, K. A. Taubert; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; and Infectious Diseases Society of America. 2005. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:e394e434.
7. Baltimore, R. S. 1985. Treatment of impetigo: a review. Pediatr. Infect. Dis. 4:597.
8. Banas, J. A. 2004. Virulence properties of Streptococcus mutans. Front. Biosci. 9:12671277.
9. Baker, C. J.,, and M. S. Edwards. 2000. Group B streptococcal infections, p. 1091–1156. In J. S. Remington and, J. O. Klein (ed.), Infectious Diseases of the Fetus and Newborn Infant, 5th ed. Saunders, Philadelphia, PA.
10. Barnham, M.,, T. J. Thornton, and, K. Lange. 1983. Nephritis caused by Streptococcus zooepidemicus (Lancefield group C). Lancet i:945948.
11. Ben-Abraham, R.,, N. Keller,, R. Vered,, R. Harel,, Z. Barzilay, and, G. Paret. 2002. Invasive group A streptococcal infections in a large tertiary center: epidemiology, characteristics and outcome. Infection 30:8185.
12. Bernaldo de Quiros, J. C.,, S. Moreno,, E. Cercenado,, D. Diaz,, J. Berenguer,, P. Miralles,, P. Catalán, and, E. Bouza. 1997. Group A streptococcal bacteremia. A 10-year prospective study. Medicine 76:238248.
13. Bessen, D. E.,, L. G. Veasy,, H. R. Hill,, N. H. Augustine, and, V. A. Fischetti. 1995. Serologic evidence for a class I goup A streptococcal infection among rheumatic fever patients. J. Infect. Dis. 172:16081611.
14. Bisno, A. L. 1990. The resurgence of acute rheumatic fever in the United States. Annu. Rev. Med. 41:319329.
15. Botta, G. A. 1981. Surface components in adhesion of group A streptococci to pharyngeal epithelial cells. Curr. Microbiol. 6:101104.
16. Boyce, J. 1997. Epidemiology and prevention of nosocomial infections, p. 309–329. In K. B. Crossley and, G. L. Archer (ed.), Staphylococci in Human Disease. Churchill Livingstone, New York, NY.
17. Bronze, M. S.,, and J. B. Dale. 1996. The reemergence of serious group A streptococcal infections and acute rheumatic fever. Am. J. Med. Sci. 311:4154.
18. Carapetis, J. R.,, A. C. Steer,, E. K. Mulholland, and, M. Weber. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685694.
19. Chambers, H. F. 2001. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7:178182.
20. Chambers, H. F.,, B. J. Hartman, and, A. Tomasz. 1985. Increased amounts of a novel penicillin binding protein in a strain of methicillin-resistant Staphylococcus aureus. J. Clin. Investig. 76:325331.
21. Chang, F. Y.,, B. B. MacDonald,, J. E. Peacock. Jr.,, D. M. Musher,, P. Triplett,, J. M. Mylotte,, A. O’Donnell,, M. M. Wagener, and, V. L. Yu. 2003. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 82:322332.
22. Chang, F. Y.,, J. E. Peacock,, D. M. Musher,, B. B. MacDonald,, J. M. Mylotte,, A. O’Donnell,, M. M. Wagener, and, V. L. Yu. 2003. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 82:333339.
23. Chang, S.,, D. M. Sievert,, J. C. Hageman,, M. L. Boulton,, F. C. Tenover,, F. P. Downes,, S. Shah,, J. T. Rudrik,, G. R. Pupp,, W. J. Brown,, D. Cardo,, S. K. Fridkin, and the Vancomycin-Resistant Staphylococcus aureus Investigative Team. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348:13421347.
24. Cheung, A. L.,, K. F. Eberhardt,, E. Chung,, M. R. Yeaman,, P. M. Sullam,, M. Ramos, and, A. S. Bayer. 1994. Diminished virulence of a sar/agr mutant of Staphylococcus aureus in the rabbit model of endocarditis. J. Clin. Investig. 94:18151822.
25. Chu, V. H.,, C. H. Cabell,, E. Abrutyn,, G. R. Corey,, B. Hoen,, J. M. Miro,, L. Olaison,, M. E. Stryjewski,, P. Pappas,, K. J. Anstrom,, S. Eykyn,, G. Habib,, N. Benito,, V. J. Fowler, Jr., and International Collaboration on Endocarditis Merged Database Study Group. 2004. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin. Infect. Dis. 39:15271530.
26. Chu, V. H.,, D. R. Crosslin,, J. Y. Friedman,, S. D. Reed,, C. H. Cabell,, R. I. Griffiths,, L. E. Masselink,, K. S. Kaye,, G. R. Corey,, L. B. Reller,, M. E. Stryjewski,, K. A. Schulman, and, V. G. Fowler, Jr. 2005. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am. J. Med. 118:1416.
27. Cosgrove, S. E.,, G. Sakoulas,, E. N. Perencevich,, M. J. Schwaber,, A. W. Karchmer, and, Y. Carmeli. 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta analysis. Clin. Infect. Dis. 36:5359.
28. Cramton, S. E.,, C. Gerke,, N. F. Schnell,, W. W. Nichols, and, F. Götz. 1999. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect. Immun. 67:54275433.
29. Cui, L.,, X. Ma,, K. Sato,, K. Okuma,, F. C. Tenover,, E. M. Mamizuka,, C. G. Gemmell,, M. N. Kim,, M. C. Ploy,, N. El-Solh,, V. Ferraz, and, K. Hiramatsu. 2003. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41:514.
30. Cundell, D. R.,, B. J. Pearce,, J. Sandros,, A. M. Naughton, and, H. R. Masure. 1995. Peptide permeases from Streptococcus pneumoniae affect adherence to eukaryotic cells. Infect. Immun. 63:24932498.
31. Cunningham, M. W.,, J. M. McCormack,, P. G. Fenderson,, M. K. Ho,, E. H. Beachey, and, J. B. Dale. 1989. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J. Immunol. 143:26772683.
32. Cunningham, M. W.,, J. M. McCormack,, L. R. Talaber,, J. B. Harley,, E. M. Ayoub,, R. S. Muneer,, L. T. Chun, and, D. V. Reddy. 1988. Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart. J. Immunol. 141:2760.
33. Cunningham-Rundles, C. 1989. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J. Clin. Immunol. 9:2233.
34. Dajani, A. S.,, E. Ayoub,, F. Z. Bierman,, A. L. Bisno,, F. W. Denny,, D. T. Durack, P. Ferrieri,, M. Freed,, M. Gerber,, E. L. Kaplan,, A. W. Karchme,, M. Markowitz,, S. H. Rahimtoola,, S. T. Shulman, G. Stollerman,, M. Takahashi,, A. Taranta,, K. A. Taubert, and, W. Wilson. 1993. Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. Circulation 87:302307.
35. Dale, J. B.,, and E. H. Beachey. 1985. Epitopes of streptococcal M proteins shared with cardiac myosin. J. Exp. Med. 162:583591.
36. Davies, H. D.,, A. B. McGeer,, B. Schwartz,, K. Green,, D. Cann,, A. E. Simor,, D. E. Low, and The Ontario Group A Streptococcal Study Group. Invasive group A streptococcal infections in Ontario, Canada: Ontario Group A Streptococcal Study Group. N. Engl. J. Med. 335:547554.
37. Dillon, H. C.,, C. W. Derrick, and, M. S. Dillon. 1974. M-antigens common to pyoderma and acute glomerulonephritis. J. Infect. Dis. 130:257267.
38. Dugdale, D. C.,, and P. G. Ramsey. 1990. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am. J. Med. 89:137141.
39. Enright, M. C.,, B. G. Spratt,, A. Kalia,, J. H. Cross, and, D. E. Bessen. 2001. Multilocus Sequence Typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect. Immun. 69:2416.
40. Facklam, R. 2002. What happened to the streptococci: overview of the taxonomic and nonmenclature changes. Clin. Microbiol. Rev. 15:613630.
41. Feldman, C.,, N. C. Munro,, P. K. Jeffery,, T. J. Mitchell,, P. W. Andrew,, G. J. Boulnois,, D. Guerreiro,, J. A. Rohde,, H. C. Todd,, P. J. Cole, and, R. Wilson. 1991. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am. J. Respir. Cell. Mol. Biol. 5:416423.
42. Figueroa, J. E.,, and P. Densen. 1991. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:359395.
43. Finkelstein, R.,, J. D. Sobel,, A. Nagler, and, D. Merzbach. 1984. Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infection. J. Med. 15:193.
44. Fowler, V. J., Jr.,, H. W. Boucher,, G. R. Corey,, E. Abrutyn,, A. W. Karchmer,, M. E. Rupp,, D. P. Levine,, H. F. Chambers,, F. P. Tally,, G. A. Vigliani,, C. H. Cabell,, A. S. Link,, I. DeMeyer,, S. G. Filler,, M. Zervos,, P. Cook,, J. Parsonnet,, J. M. Bernstein,, C. S. Price,, G. N. Forrest,, G. Fätkenheuer,, M. Gareca,, S. J. Rehm,, H. R. Brodt,, A. Tice,, S. E. Cosgrove and the S. aureus Endocarditis and Bacteremia Study Group. 2006. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355:653665.
45. Fowler, V. G., Jr.,, A. Justice,, C. Moore,, D. K. Benjamin, Jr.,, C. W. Woods,, S. Campbell,, L. B. Reller,, G. R. Corey,, N. P. J. Day, and, S. J. Peacock. 2005. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin. Infect. Dis. 40:695703.
46. Fowler, V. G., Jr.,, L. Kong,, G. R. Corey,, G. S. Gottlieb,, R. S. McClelland,, D. J. Sexton,, D. Gesty-Palmer, and, L. J. Harrell. 1999. Recurrent Staphylococcus aureus bacteremia: Pulsedfield gel electrophoresis findings in 29 patients. J. Infect. Dis. 179:11571161.
47. Fowler, V. G., Jr.,, J. M. Miro,, B. Hoen,, C. H. Cabell,, E. Abrutyn,, E. Rubinstein,, G. R. Corey,, D. Spelman,, S. F. Bradley,, B. Barsic,, P. A. Pappas,, K. J. Anstrom,, D. Wray,, C. O. Fortes,, I. Anguera,, E. Athan,, P. Jones,, J. T. van der Meer,, T. S. Elliott,, D. P. Levine, and ICE Investigators. 2005. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:30123021.
48. Fowler, V. G., Jr.,, M. K. Olsen,, G. R. Corey,, C. W. Woods,, C. H. Cabell,, L. B. Reller,, A. C. Cheng,, T. Dudley, and, E. Z. Oddone. 2003. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch. Intern. Med. 163:20662072.
49. Fowler, V. G., Jr.,, L. L. Sanders,, L. K. Kong,, R. S. McClelland,, G. S. Gottlieb,, J. Li,, T. Ryan,, D. J. Sexton,, G. Roussakis,, L. J. Harrell, and, G. R. Corey. 1999. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin. Infect. Dis. 28:106114.
50. Fridkin, S. K. 2001. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin. Infect. Dis. 32:108115.
51. Friedman, N. D.,, K. S. Kaye,, J. E. Stout,, S. A. McGarry,, S. L. Trivette,, J. P. Briggs,, W. Lamm,, C. Clark,, J. MacFarquhar,, A. L. Walton,, L. B. Reller, and, D. J. Sexton. 2002. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 137:791797.
52. Frimodt-Moller, N.,, F. Espersen,, P. Skinhoj, and, V. T. Rosdahl. 1997. Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990. Clin. Microbiol. Infect. 3:297.
53. Galvin, J. E.,, M. E. Hemric,, K. Ward, and, M. W. Cunningham. 2000. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J. Clin. Investig. 106:217224.
54. Garvey, M. A.,, S. J. Perlmutter,, A. J. Allen,, S. Hamburger,, L. Lougee,, H. L. Leonard,, M. E. Witowskiet,, B. Dubbert, and, S. E. Swedo. 1999, A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol. Psych. 45:15641571.
55. Gerber, M. A. 1995. Antibiotic resistance in group A streptococci. Pediatr. Clin. North Am. 42:539551.
56. Giannitsioti, E.,, C. Chirouze,, A. Bouvet,, I. Béguinot,, F. Delahaye,, J. L. Mainardi,, M. Celard,, L. Mihaila-Amrouche,, V. L. Moing,, B. Hoen, and AEPEI Study Group. 2007. Characteristics and regional variations of group D streptococcal endocarditis in France. Clin. Microbiol. Infect. 13:770776.
57. Goroncy-bermes, P.,, J. B. Dale,, E. H. Beachey, and, W. Opferkuch. 1987. Monoclonal antibody to human renal glomeruli cross-reacts with streptococcal M protein. Infect. Immun. 55:24162419.
58. Granlund, M.,, L. Oberg,, M. Sellin, and, M. Norgren. 1998. Identification of a novel insertion element IS1548, in group B streptococci, predominantly in strains causing endocarditis. J. Infect. Dis. 177:967976.
59. Hanaki, H.,, K. Kuwahara-Arai,, S. Boyle-Vavra,, R. S. Daum,, H. Labischinski, and, K. Hiramatsu. 1998. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J. Antimicrob. Chemother. 42:199209.
60. Hansan, S. M.,, N. Uldbjerg,, M. Killian, and, U. B. Sorensen. 2004. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J. Clin. Microbiol. 42:8389.
61. Harbarth, S.,, O. Rutschmann,, P. Sudre, and, D. Pittet. 1998. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch. Intern. Med. 158:182189.
62. Harrison, L. H.,, A. Ali,, D. M. Dwyer,, J. P. Libonati,, M. W. Reeves,, J. A. Elliott,, L. Billmann,, T. Lashkerwala, and, J. A. Johnson. 1995. Relapsing invasive group B streptococcal infection in adults. Ann. Intern. Med. 123:421427.
63. Harrison, L. H.,, J. A. Elliott,, D. M. Dwyer,, J. P. Libonati,, P. Ferrieri,, L. Billmann, and, A. Schuchat. 1998. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J. Infect. Dis. 177:9981002.
64. Hartstein, A. I.,, M. E. Mulligan,, V. H. Morthland, and, R. Y. Kwok. 1992. Recurrent Staphylococcus aureus bacteremia. J. Clin. Microbiol. 30:670674.
65. Heikens, E.,, A. Fleer,, A. Paauw,, A. Florijn, and, A. C. Fluit. 2005. Comparison of genotypic and phenotypic methods for species-level identification of clinical isolates of coagulase-negative staphylococci. J. Clin. Microbiol. 43:22862290.
66. Heilmann, C.,, O. Schweitzer,, C. Gerke,, N. Vanittanakom,, D. Mack, and, F. Götz. 1996. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 20:10831091.
67. Hoen, B.,, C. Chirouze,, C. H. Cabell,, C. Selton-Suty,, F. Duchêne,, L. Olaison,, J. M. Miro,, G. Habib,, E. Abrutyn,, S. Eykyn,, Y. Bernard,, F. Marco,, G. R. Corey, and International Collaboration on Endocarditis Study Group. 2005. Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis Study Group. Eur. J. Clin. Microbiol. Infect. Dis. 24:1216.
68. Huebner, J.,, and D. A. Goldman. 1999. Coagulase-negative staphylococci: role as pathogens. Ann. Rev. Med. 50:223236.
69. Hussain, M.,, A. Haggar,, C. Heilmann,, G. Peters,, J. I. Flock, and, M. Herrmann. 2002. Insertional inactivation of Eap in Staphylococcus aureus strain Newman confers reduced staphylococcal binding to fibroblasts. Infect. Immun. 70:29332940.
70. Ing, M. B.,, L. M. Baddour, and, A. S. Bayer. 1997. Bacteremia and infective endocarditis: pathogenesis, diagnosis, and complications, p. 331–354. In K. B. Crossley and, G. L. Archer, (ed.), The Staphylococci in Human Disease. Churchill Livingstone, New York, NY.
71. Ito, T.,, K. Okuma,, X. X. Ma,, H. Yuzawa, and, K. Hiramatsu. 2003. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist. Updat. 6:4152.
72. Janoff, E. N.,, J. O’Brien,, P. Thompson,, J. Ehret,, G. Meiklejohn,, G. Duvall, and, J. M. Douglas, Jr. 1993. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J. Infect. Dis. 167:4956.
73. Johnson, D. R.,, D. L. Stevens, and, E. L. Kaplan. 1992. Epidemiological analysis of GAS serotypes associated with severe systemic infections, rheumatic fever or uncomplicated pharyngitis. J. Infect. Dis. 166:374382.
74. Johri, A. K.,, L. C. Paoletti,, P. Glaser,, M. Dua,, P. K. Sharma,, G. Grandi, and, R. Rappuoli. 2006. Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 4:932942.
75. Kadioglu A.,, J. N. Weiser,, J. C. Paton, and, P. W. Andrew. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6:288301.
76. Kaplan, E. L.,, D. R. Johnson, and, P. P. Cleary. 1989. GAS serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the US in the mid-1980s. J. Infect. Dis. 159:10101011.
77. Katayama, Y.,, T. Ito, and, K. Hiramatsu. 2000. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 44:15491555.
78. Khanna, A. K.,, D. R. Buskirk,, R. C. Williams, Jr.,, A. Gibofsky,, M. K. Crow,, A. Menon,, M. Forino,, H. M. Reid,, T. Poon-King,, P. Rubinstein, and, J. B. Zabriskie. 1989. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J. Clin. Investig. 83:17101716.
79. Khatib, R.,, L. B. Johnson,, M. G. Fakih,, K. Riederer,, A. Khosrovaneh,, M. Shamse Tabriz,, M. Sharma, and, S. Saeed. 2006. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome. Scand. J. Infect. Dis. 38:714.
80. Kim, E. L.,, D. L. Ching, and, F. D. Pien. 1990. Bacterial endocarditis at a small community hospital. Am. J. Med. Sci. 299:8793.
81. Kim, P.,, D. M. Musher,, W. P. Glezen,, M. C. Rodriguez-Barradas,, W. K. Nahm, and, C. E. Wright. 1996. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin. Infect. Dis. 22:100106.
82. Klein, R. S.,, R. A. Recco,, M. T. Catalano,, S. C. Edberg,, J. I. Casey, and, N. H. Steigbigel. 1977. Association of Streptococcus bovis with carcinoma of the colon. N. Engl. J. Med. 297:800802.
83. Kloos, W. 1997. Taxonomy and systematics of staphylococci indigenous to humans, p. 113–137. In K. B. Crossley and, G. L. Archer (ed.), The Staphylococci in Human Disease. Churchill Livingstone, New York, NY.
84. Kluytmans, J.,, A. van Belkum, and, H. Verbrugh. 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10:505520.
85. Lalani, T.,, Z. Kanafani,, V. H. Chu,, L. L. Moore,, G. R. Corey,, P. Pappas,, C. W. Woods,, C. H. Cabell,, B. Hoen,, C. Selton-Suty,, L. Doco-Lecompte,, C. Chirouze,, D. Raoult,, J. M. Miro,, C. A. Mestres,, L. Olaison,, S. Eykyn,, E. Abrutyn,, V. G. Fowler, Jr., and The International Collaboration on Endocarditis Merged Database Study Group. 2006. Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. Eur. J. Clin. Microbiol. Infect. Dis. 25:365368.
86. Lancefield, R. C. 1962. Current knowledge of type-specific M antigens of group A streptococci. J. Immunol. 89:307313.
87. Laupland, K. B.,, D. L. Church,, M. Mucenski,, L. R. Sutherland, and, H. D. Davies. 2003. Population-based study of the epidemiology and the risk factors for invasive Staphylococcus aureus infections. J. Infect. Dis. 187:14521459.
88. Lautenschlager, S.,, C. Herzog, and, W. Zimmerli. 1993. Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different case definitions. Clin. Infect. Dis. 16:567573.
89. Lee, L. Y.,, Y. J. Miyamoto,, B. W. McIntyre,, M. Höök,, K. W. McCrea,, D. McDevitt, and, E. L. Brown. 2002. The Staphylococcus aureus MAP protein in an immunomodulator that interferes with T cell-mediated responses. J. Clin. Investig. 110:14611471.
90. Leentnek, A. L.,, O. Giger, and, E. O’Rourke. 1990. Group A beta-hemolytic streptococcal bacteremia and intravenous substance abuse: a growing clinical problem? Arch. Intern. Med. 150:8993.
91. Levine, D. P.,, B. S. Fromm, and, B. R. Reddy. 1991. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115:674680.
92. Light, R. W.,, W. M. Girard,, S. G. Jenkinson, and, R. B. George. 1980. Parapneumonic effusions. Am. J. Med. 69:507512.
93. Lin, F. Y.,, P. H. Azimi,, L. E. Weisman,, J. B. Philips III,, J. Regan,, P. Clark,, G. G. Rhoads,, J. Clemens,, J. Troendle,, E. Pratt,, R. A. Brenner, and, V. Gill. 2000. Susceptibility profiles for group B streptococci isolated from neonates, 1995–1998. Clin. Infect. Dis. 31:7679.
94. Lin, F. Y.,, J. D. Clemens,, P. H. Azimi,, J. A. Regan,, L. E. Weisman,, J. B. Philips III,, G. G. Rhoads,, P. Clark,, R. A. Brenner, and, P. Ferrieri. 1998. Capsular polysaccharide types of group B streptococcal isolates from neonates with earlyonset systemic infection. J. Infect. Dis. 177:790792.
95. Lowrance, J. H.,, L. M. Baddour, and, W. A. Simpson. 1990. The role of fibronectin binding in the rat model of experimental endocarditis caused by Streptococcus sanguis. J. Clin. Investig. 86:713.
96. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520532.
97. Maki, D. G.,, D. M. Kluger, and, C. J. Crnich. 2006. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin. Proc. 81:11591171.
98. Maki, D. G.,, C. E. Weise, and, H. W. Sarafin. 1977. A semi-quantitative culture method for identifying intravenous-catheter-related infection. N. Engl. J. Med. 296:13051309.
99. Marr, K. A.,, D. J. Sexton,, P. J. Conlon,, G. R. Corey,, S. J. Schwab, and, K. B. Kirkland. 1997. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann. Intern. Med. 127:275280.
100. Martin, G. S.,, D. M. Mannino,, S. Eaton, and, M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:15461554.
101. Miller, D. L.,, and R. M. Laxe. 2003. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Pediatr. Rheumatol. Online J. 1:140161. http://www.pedrheumonlinejournal.org/April/review-arti.htm.
102. Monk, A. B.,, S. Boundy,, V. H. Chu., J. C. Bettinger,, J. R. Robles,, V. J. Fowler, Jr., and, G. L. Archer. 2008. Analysis of the genotype and virulence of Staphylococcus epidermidis isolates from patients with infective endocarditis. Infect. Immun. 76:51275132.
103. Moyer, M. A.,, L. D. Edwards, and, L. Farley. 1983. Comparative culture methods on 101 intravenous catheters. Routine, semiquantitative, and blood cultures. Arch. Intern. Med. 143:6669.
104. Munoz, P.,, A. Llancaqueo,, M. Rodriguez-Creixems,, T. Peláez,, L. Martin, and, E. Bouza. 1997. Group B streptococcus bacteremia in nonpregnant adults. Arch. Intern. Med. 157:213216.
105. Murphy, M. L.,, and M. E. Pichichero. 2002. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with Group A streptococcal infection (PANDAS). Arch. Pediatr. Adolesc. Med. 156:356361.
106. Musher, D. M.,, J. E. Groover,, D. A. Watson,, J. P. Pandey,, M. C. Rodriguez-Barradas,, R. E. Baughn,, M. S. Pollack,, E. A. Graviss,, M. de Andrade, and, C. I. Amos. 1997. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J. Invest. Med. 45:5768.
107. Mylotte, J. M.,, J. R. Aeschlimann, and, D. L. Rotella. 1996. Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infect. Control Hosp. Epidemiol. 17:165168.
108. Nielsen, H. U.,, H. J. Kolmos, and, N. Frimodt-Moller. 2002. Beta-hemolytic streptococcal bacteremia: a review of 241 cases. Scand. J. Infect. Dis. 34:483.
109. NNIS. 1999. Data summary from January 1990-May 1999. Am. J. Infect. Control 27:520532.
110. Noble, W. C.,, Z. Virani, and, R. G. A. Cree. 1992. Cotransfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12001 to Staphylococcus aureus. FEMS Microbiol. Lett. 93:195198.
111. Novick, R. P. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48:14291449.
112. Nunes, A. P.,, L. M. Teixeira,, N. L. Iorio,, C. C. Bastos,, L. de Sousa Fonesca,, T. Souto-Padron, and, K. R. dos Santos. 2006. Heterogenous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus, and Staphylococcus warneri clinical strains: characterization of glycopeptide susceptibility profiles and cell wall thickening. Int. J. Antimicrob. Agents 27:307315.
113. Parker, M. T.,, and L. C. Ball. 1976. Streptococci and aerococci associated with systemic infection in man. J. Med. Microbiol. 9:275302.
114. Patti, J. M.,, T. Bremell,, D. Krajewska-Pietrasik,, A. Abdelnour,, A. Tarkowski,, C. Rydén, and, M. Höök. 1994. The Staphylococcus aureus collagen adhesion is a virulence determinant in experimental septic arthritis. Infect. Immun. 62:152161.
115. Peterson, P. K.,, J. Verhoef,, L. D. Sabath, and, P. G. Quie. 1977. Effect of protein A on staphylococcal opsonization. Infect. Immun. 15:760764.
116. Petti, C. A.,, K. E. Simmon,, J. M. Miro,, B. Hoen,, F. Marco,, V. H. Chu,, E. Athan,, S. Bukovski,, E. Bouza,, S. Bradley,, V. J. Fowler,, E. Giannitsioti,, D. Gordon,, P. Reinbott,, T. Korman,, S. Lang,, C. Garcia de-la-Maria,, A. Raglio,, A. J. Morris,, P. Plesiat,, S. Ryan,, T. Doco-Lecompte,, F. Tripodi,, R. Utili,, D. Wray,, J. J. Federspiel,, K. Boisson,, L. B. Reller,, D. R. Murdoch,, C. W. Woods, and International Collaboration on Endocarditis-Microbiology Investigators. 2008. Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J. Clin. Microbiol. 46:17801784.
117. Que, Y. A.,, P. Francois,, J. A. Haefliger,, J. M. Entenza,, P. Vaudaux, and, P. Moreillon. 2001. Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infect. Immun. 69:62966302.
118. Roberts, R. B. 1992. Streptococcal endocarditis: the viridans and beta hemolytic streptococci, p.191. In D. Kaye (ed), Infective Endocarditis, Raven Press, Ltd, New York, NY.
119. Rodriguez-Barradas, M. C.,, D. M. Musher,, C. Lahart,, C. Lacke,, J. Groover,, D. Watson,, R. Baughn,, T. Cate, and, G. Crofoot. 1992. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J. Infect. Dis. 165:553556.
120. Rollán, M. J.,, J. A. San Román,, I. Vilacosta,, C. Sarriá,, J. López,, M. Acuña, and, J. L. Bratos. 2003. Clinical profile of Streptococcus agalactiae native valve endocarditis. Am. Heart J. 146:10951098.
121. Rubins, J. B.,, D. Charboneau,, J. C. Paton,, T. J. Mitchell,, P. W. Andrew, and, E. N. Janoff. 1995. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J. Clin. Investig. 95:142150.
122. Rubins, J. B.,, and E. N. Janoff. 1998. Pneumolysin: a multifunctional pneumococcal virulence factor. J. Lab. Clin. Med. 131:2127.
123. Ruoff, K. L.,, S. I. Miller,, C. V. Garner,, M. J. Ferraro, and, S. B. Calderwood. 1989. Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J. Clin. Microbiol. 27:305308.
124. Rupp, M. E.,, and G. L. Archer. 1994. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin. Infect. Dis. 19:231243.
125. Sanders, L. A.,, G. T. Rijkers,, W. Kuis,, A. J. Tenbergen-Meekes,, B. R. de Graeff-Meeder,, I. Hiemstra, and, B. J. Zegers. 1993. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections. J. Allergy Clin. Immunol. 91:110119.
126. Sanyal, D.,, A. P. Johnson,, R. C. George,, B. D. Cookson, and, A. J. Williams. 1991. Peritonitis due to vancomycin-resistant Staphylococcus epidermidis. Lancet 337:54.
127. Savage, D. G.,, J. Lindenbaum, and, T. J. Garrett. 1982. Biphasic pattern of bacterial infection in multiple myeloma. Ann. Intern. Med. 96:4750.
128. Schuchat, A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497513.
129. Schwalbe, R. S.,, J. T. Stapletone, and, P. H. Gilligan. 1987. Emergence of vancomycin resistance in coagulase-negative staphylococci. N. Engl. J. Med. 316:927.
130. Schwartz, B.,, and X. T. Ussery. 1992. Group A streptococcal outbreaks in nursing homes. Infect. Control Hosp. Epidemiol. 13:742747.
131. Seppälä, H.,, A. Nissinen,, H. Järvinen,, S. Huovinen,, T. Henriksson,, E. Herva,, S. E Holm,, M. Jahkola,, M. L. Katila,, T. Klaukka,, S. Kontiainen,, O. Liimatainen,, S. Oinonen,, L. Passi-Metsomaa, and, P. Huovinen. 1992. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:292297.
132. Shet, A.,, and P. Ferrieri. 2004. Neonatal and maternal group B streptococcal infections: a comprehensive review. Indian J. Med. Res. 120:141150.
133. Shulman, S. T.,, G. Stollerman,, B. Beall,, J. B. Dale, and, R. R. Tanz. 2006. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin. Infect. Dis. 42:441447.
134. Sieradzki, K.,, M. G. Pinho, and, A. Tomasz. 1999. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J. Biol. Chem. 274:1894218946.
135. Sieradzki, K.,, and A. Tomasz. 1999. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J. Bacteriol. 181:75667570.
136. Simmon, K. E.,, L. Hall,, C. W. Woods,, F. Marco,, J. M. Miro,, C. Cabell,, B. Hoen,, M. Marin,, R. Utili,, E. Giannitsioti,, T. Doco-Lecompte,, S. Bradley,, S. Mirrett,, A. Tambic,, S. Ryan,, D. Gordon,, P. Jones,, T. Korman,, D. Wray,, L. B. Reller,, M. E. Tripodi,, P. Plesiat,, A. J. Morris,, S. Lang,, D. R. Murdoch,, C. A Petti, and International Collaboration on Endocarditis Microbiology Investigators. 2008. Phylogenetic analysis of viridans group streptococci causing endocarditis. J. Clin. Microbiol. 46:30873090.
137. Skinner, D.,, and C. S. Keefer. 1941. Significance of bacteremia caused by Staphylococcus aureus. A study of 122 cases and a review of the literature concerned with experimental infection in animals. Arch. Intern. Med. 68:851.
138. Small, P. M.,, and H. F. Chambers. 1990. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob. Agents Chemother. 34:12271231.
139. Snider, L. A.,, and S. E. Swedo. 2003. Childhood-onset obsessive disorder and tic disorders: case report and literature review. J. Child. Adolesc. Psychopharmacol. 13(Supp. 1):S81S88.
140. Snider, L. A.,, and S. E. Swedo. 2004. PANDAS: current status and directions for research. Mol. Psych. 9:900907.
141. Steinberg, J. P.,, C. C. Clark, and, B. O. Hackman. 1996. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin. Infect. Dis. 23:255259.
142. Stevens, D. L. 1992. Invasive group A streptococcus infections. Clin. Infect. Dis. 14:211.
143. Stollerman, G. H. 1975. Rheumatic Fever and Streptococcal Infection. Grune and Stratton, New York, NY.
144. Umetsu, D. T.,, D. M. Ambrosino,, I. Quinti,, G. R. Siber, and, R. S. Geha. 1985. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG subclass deficiency. N. Engl. J. Med. 313:12471251.
145. Valente, A. M.,, R. Jain,, M. Scheurer,, V. G. Fowler, Jr.,, G. R. Corey,, A. R. Bengur,, S. Sanders, and, J. S. Li. 2005. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics 115:e15e19.
146. Van de Rijn, I.,, J. B. Zabriskie, and, M. McCarty. 1977. Group A streptococcal antigens cross-reactive with myocardium: purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J. Exp. Med. 146:579.
147. Veach, L. A.,, M. A. Pfaller,, M. Barrett,, F. P. Koontz, and, R. P. Wenzel. 1990. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J. Clin. Microbiol. 28:20641068.
148. Veasy, L. G.,, L. Y. Tani, and, H. R. Hill. 1994. Persistence of acute rheumatic fever in the intermountain area of the United States. J. Pediatr. 124:916.
149. von Eiff, C.,, K. Becker,, K. Machka,, H. Stammer,, G. Peters, et al. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:1116.
150. Wannamaker, L. W. 1970. Differences between streptococcal infections of the throat and of the skin. N. Engl. J. Med. 282:2331.
151. Watanakunakorn, C. 1999. Increasing importance of intravascular device-associated Staphylococcus aureus endocarditis. Clin. Infect. Dis. 28:115116.
152. Weinstein, M. P.,, M. L. Towns,, S. M. Quartey,, S. Mirrett,, L. G. Reimer,, G. Parmigiani, and, L. B. Reller. 1997. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24:584602.
153. Weiser, J. N.,, Z. Markiewicz,, E. I. Tuomanen, and, J. H. Wani. 1996. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae. Infect. Immun. 64:22402245.
154. Wessels, M. R.,, C. E. Rubens,, V. J. Benedí, and, D. L. Kasper. 1989. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc. Natl. Acad. Sci. USA 86:89838987.
155. Wheeler, M. C.,, M. H. Roe,, E. L. Kaplan,, P. M. Schlievert, and, J. K. Todd. 1991. Outbreak of group A streptococcus septicemia in children: clinical, epidemiologic, and microbiological correlates. JAMA 266:533537.
156. Willcox, P. A.,, B. L. Rayner, and, D. A. Whitelaw. 1998. Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs. Q. J. Med. 91:4147.
157. Winston, D. J.,, D. V. Dudnick,, M. Chapin,, W. G. Ho,, R. P. Gale, and, W. J. Martin. 1983. Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch. Intern. Med. 143:3236.
158. Wisplinghoff, H.,, T. Bischoff,, S. M. Tallent,, H. Seifert,, R. P. Wenzel, and, M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309.
159. Wisplinghoff., H.,, A. E. Rosato,, M. C. Enright,, M. Noto,, W. Craig, and, G. L. Archer. 2003. Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolates. Antimicrob. Agents Chemother. 47:35743579.
160. Yee, A. M.,, H. M. Phan,, R. Zuniga,, J. E. Salmon, and, D. M. Musher. 2000. Association between FcgammaRIIa-R131 allotype and bacteremic pneumonococcal pneumonia. Clin. Infect. Dis. 30:2528.
161. Zabriskie, J. B. 1985. Rheumatic fever: the interplay between host, genetics, and microbe. Lewis A. Conner Memorial Lecture. Circulation 71:10771086.

Tables

Generic image for table
Table 1.

Diagnosis of acute rheumatic fever: the Jones criteria ( )

Citation: Ferguson B, Woods C. 2009. Variable Capacity for Persistent Infection and Complications of Gram-Positive Cocci: Streptococci and Staphylococci, p 87-106. In Fratamico P, Smith J, Brogden K (ed), Sequelae and Long-Term Consequences of Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555815486.ch6

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error